Andrew E. Sloan, MD, has been included in Marquis Who’s Who for his work in neurosurgery. The news came from Cleveland on January 15, 2018. Marquis picks the people it profiles for their current reference value, which takes in their position, accomplishments, visibility and standing in their field.
Dr. Sloan is a professor and vice chair of the Department of Neurological Surgery at Case Western Reserve University. In that role he reports to the chairman on clinical and research work. He also oversees the Brain Tumor and Neurological Program, and he has nearly 20 years of experience in medicine.
He is seen as a pioneer of immunotherapy for brain tumors. In addition, he helped develop Laser Interstitial Thermal Therapy, a surgical method that has improved along with new technology. His research covers brain tumors, convection-enhanced delivery, gamma knife and CyberKnife radiosurgery, image-guided and skull base surgery, and tumor vaccines.
Dr. Sloan also founded a company that builds simulations of brain tumor surgery. The idea borrows from aviation. Just as pilots train in simulators before they get a license, surgeons can rehearse an operation first.
His training began at Yale University, where he earned a Bachelor of Science in biology in 1985. Five years later, in 1990, he received his MD from Harvard Medical School. He then trained in neurosurgery at UCLA, serving as chief resident from 1996 to 1997, and completed a fellowship at the University of Texas MD Anderson Cancer Center.
In 1999, he started his academic career as an associate professor at Wayne State University, where he directed the Brain Tumor and Neuro-oncology Center. Since 2007, he has held several posts at University Hospitals. He directs the Brain Tumor and Neuro-oncology Center at University Hospitals Seidman Cancer Center and holds the Peter D. Cristal Chair of Neurosurgery. He also directs stereotactic radiosurgery at University Hospitals Case Medical Center. In 2014, he became professor and vice chair at Case Western Reserve.
In 2016, the Congress of Neurological Surgeons gave him its Neuro-oncology Award. Earlier, he received a Clinical Research Career Development Award from the American Society of Clinical Oncology and a Clinician Investigator Award from the American Brain Tumor Association. He belongs to the Congress of Neurological Surgeons, the American Society of Clinical Oncology and the American Association of Neurological Surgeons. He once served a year as president of the Ohio State Neurosurgical Society.
Looking ahead, Dr. Sloan plans to keep leading clinical trials for malignant brain tumors and to head a national program in the field.
